HAYWARD, Calif., Sept. 7, 2016 /PRNewswire/ -- Impax
Laboratories, Inc. (NASDAQ: IPXL) today announced that
Fred Wilkinson, president and chief
executive officer, and Bryan
Reasons, chief financial officer, will present at the
Morgan Stanley Global Healthcare Conference on Wednesday, September 14, 2016 at 1:35 p.m. Eastern Time.
Individuals may listen to the live or an archived presentation
made at the conference, which will be posted in the investor
relations section of the Company's web site at
www.impaxlabs.com. This presentation will be archived on the
Company's web site for 90 days.
About Impax Laboratories, Inc.
Impax Laboratories, Inc. (Impax) is a specialty pharmaceutical
company applying its formulation expertise and drug delivery
technology to the development of controlled-release and specialty
generics in addition to the development of central nervous system
disorder branded products. Impax markets its generic products
through its Impax Generics division and markets its branded
products through the Impax Specialty Pharma division. Additionally,
where strategically appropriate, Impax develops marketing
partnerships to fully leverage its technology platform and pursues
partnership opportunities that offer alternative dosage form
technologies, such as injectables, nasal sprays, inhalers, patches,
creams, and ointments. For more information, please visit the
Company's Web site at: www.impaxlabs.com.
Company
Contacts:
Mark Donohue
Investor Relations and Corporate
Communications
(215)
558-4526
www.impaxlabs.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/impax-to-present-at-the-morgan-stanley-global-healthcare-conference-300323710.html
SOURCE Impax Laboratories, Inc.